HUTCHMED (CHINA) LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 346 GBX | -1.14% |
|
+12.34% | +22.26% |
| 05:11am | Hutchmed Starts Phase 2/3 Trials for Pancreatic Cancer Drug in China; Shares Rise 3% | MT |
| 05:01am | Hutchmed Begins Phase 3 Trials for Leukemia Medication in China | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.75B | - | |||||
| 682B | ||||||
| 586B | ||||||
| 364B | ||||||
| 327B | ||||||
| 285B |
